Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Genetic Control of Oxytetracycline Biosynthesis

Abstract

MORE than ten years ago Bonner1 made an unsuccessful attempt to use inactive variants and biochemical mutants of Penicillium chrysogenum for studying the mechanism of penicillin biosynthesis. Since that time the mechanism of the biosynthesis of the antibiotic has apparently not been investigated in this way.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Bonner, D., Arch. Biochem., 3, 1 (1947).

    Google Scholar 

  2. Mindlin, S. Z., and Alikhanian, S. I., Doklady Akademyi Nauk SSSR, 111, 4, 884 (1956).

    Google Scholar 

  3. Selzer, G. B., Wright, W. W., Antibiot. and Chemother., 7, 6, 292 (1957).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

ALIKHANIAN, S., ORLOVA, N., MINDLIN, S. et al. Genetic Control of Oxytetracycline Biosynthesis. Nature 189, 939–940 (1961). https://doi.org/10.1038/189939b0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/189939b0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing